The latest medical research on Neuroendocrine Tumors

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about neuroendocrine tumors gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access

RAB5A polarizes macrophage and promotes breast cancer.

Neuroendocrine Tumors

Breast cancer is the leading cause of cancer-related deaths in females, and triple-negative breast cancer (TNBC) is characterized as one of the mai...

HSPB1 promotes tumor invasion by inducing angiogenesis in PitNETs.

Neuroendocrine Tumors

The clinical diagnosis and treatment of Pituitary neuroendocrine tumors (PitNETs) that invade the cavernous sinus are fraught with difficulties and...

Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the United States, 2000-2020: a population-based retrospective cohort study.

Neuroendocrine Tumors

The incidence rate of medullary thyroid carcinoma (MTC) continues to grow, along with its mortality rate in the United States. However, the subgrou...

Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma.

Neuroendocrine Tumors

We developed a novel contemporary population-based model for predicting cancer-specific survival (CSS) in adrenocortical carcinoma (ACC) patients a...

Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.

Neuroendocrine Tumors

We observed that some patients with well-differentiated neuroendocrine tumors (NETs) who received peptide receptor radionuclide therapy (PRRT) with...

Bioengineered in vitro three-dimensional tumor models in endocrine cancers.

Neuroendocrine Tumors

Endocrine tumors are a heterogeneous cluster of malignancies that originate from cells that can secrete hormones. Examples include, but are not lim...

Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.

Neuroendocrine Tumors

Pralsetinib has been proven efficacious activity in a variety of solid tumors including medullary thyroid cancer (MTC) in the phase 1/2 global ARRO...

Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.

Neuroendocrine Tumors

In advanced pancreatic neuroendocrine neoplasms (PanNEN), there is little data detailing the frequency of genetic alterations identified in cell fr...

Immunotherapy for endocrine tumours : a clinician's perspective.

Neuroendocrine Tumors

Immunotherapy has revolutionised the treatment of oncological patients, but its application in various endocrine tumours is rather limited and is m...

Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.

Neuroendocrine Tumors

Adrenocortical carcinoma (ACC) is a malignancy with a poor prognosis and high mortality rate. A high tumor mutational burden (TMB) has been found t...

Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.

Neuroendocrine Tumors

The chemotherapy regimen capecitabine/temozolomide (CAPTEM) is routinely used in neuroendocrine tumors (NET), with antitumor activity particularly ...